BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Genetown

  Haemonetics to Present at Raymond James 45th Annual Institutional Investors Conference

  Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5, 2024 at 7:30 a.m. ET.

  February 21, 2024

   · 

  1 min read
• Business

  PrepMD Partners with MediaSphere and Esteemed Cardiac Experts for Groundbreaking Virtual Device Clinic Leadership Summit

  PrepMD, as the exclusive sponsor, is thrilled to announce its partnership with MediaSphere and distinguished cardiac professionals, including Beth Davenport and Sallie Gustafson, to present the largest-ever virtual accredited Cardiac Device Clinic Leadership Summit.

  February 21, 2024

   · 

  3 min read
• Policy

  Servier Receives Regulatory Filing Acceptances from FDA and EMA for Vorasidenib in the Treatment of IDH-Mutant Diffuse Glioma

  Servier today announced the FDA filing acceptance and priority review for a New Drug Application (NDA) for vorasidenib, as well as the EMA granting accelerated assessment for the vorasidenib Marketing Authorization Application (MAA).

  February 21, 2024

   · 

  12 min read
• Business

  Patterson Companies Fiscal 2024 Third Quarter Conference Call Scheduled for Wednesday, February 28, 2024

  Patterson Companies announced that it will hold its fiscal 2024 third-quarter call on Wednesday, February 28, 2024, at 7:30 a.m. CT.

  February 21, 2024

   · 

  1 min read
• Everest Medicines’ Partner Pfizer Announces European Commission Approves VELSIPITY® for Patients with Moderately to Severely Active Ulcerative Colitis

  Everest Medicines (HKEX 1952.HK, “Everest”, or the “Company”)'s partner Pfizer Inc. (NYSE: PFE) announced that the European Commission (EC) has granted marketing authorization for VELSIPITY®.

  February 21, 2024

   · 

  5 min read
• Biotech Bay

  AIXSCAN, INC. ARC60 Started Imaging Patients in the U.S.

  AIxSCAN, Inc. began clinical trials in late 2023.

  February 21, 2024

   · 

  2 min read
• Business

  Genomma Lab Internacional Reports Fourth Quarter & Full Year 2023 Results

  Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) (“Genomma Lab” or “the Company”), today announced its results for the fourth quarter and full year ended December 31, 2023.

  February 21, 2024

   · 

  5 min read